Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Galectin-9—An Emerging Glyco-Immune Checkpoint Target for Cancer Therapy

International Journal of Molecular Sciences(2025)10.3390/ijms26167998Source: DataRank Database

Galectin-9—An Emerging Glyco-Immune Checkpoint Target for Cancer Therapy is a research paper published in International Journal of Molecular Sciences (2025). On theSindex it has a DataRank of 0. It has been cited 13 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access13 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 5.63)OA: goldTopics (28)IDs (PubMed, PMC, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Tobias Schatton ORCID,Steven R. Barthel ORCID,Anastasia Iris Karkempetzaki

Live enrichment

PubMed:40869319 PMC:PMC12386273 OpenAlex:https://openalex.org/W4413329994

NIH/NCI

Grant: R01CA258637

NIH/NCI

Grant: R01CA247957

NIH HHS

Grant: 1R01CA247957-25

NIH HHS

Grant: 1R01CA258637-25

FWCI

5.63

Citation Percentile

1.0%

Citation Trend

2025

2026

goldLicense: cc-by

journalhttps://doi.org/10.3390/ijms26167998

publisherhttps://doi.org/10.3390/ijms26167998

publisherhttps://www.mdpi.com/1422-0067/26/16/7998/pdf

repositoryhttps://pubmed.ncbi.nlm.nih.gov/40869319

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/12386273

Fields of Study

Galectins and Cancer BiologyToxin Mechanisms and Immunotoxins

MeSH Terms

Immune Checkpoint InhibitorsAnimalsHumansImmunotherapyNeoplasmsGalectinsTumor Microenvironment

Keywords

GalectinImmune systemBiologyGalectin-1Immune checkpointCancer immunotherapyImmunotherapyCancer researchCarcinogenesisTumor microenvironmentCancerCell biologyImmunologyGeneticsPD-1TIM-3glycobiologyGalectinsGalectin-9